Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data

Steven J. Novick, Wei Zhao and Harry Yang
PDA Journal of Pharmaceutical Science and Technology January 2017, 71 (1) 20-32; DOI: https://doi.org/10.5731/pdajpst.2016.006684
Steven J. Novick
MedImmune LLC, Gaithersburg, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Zhao
MedImmune LLC, Gaithersburg, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry Yang
MedImmune LLC, Gaithersburg, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 71 no. 1 20-32
DOI 
https://doi.org/10.5731/pdajpst.2016.006684
PubMed 
27516490

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online February 6, 2017.

Article Versions

  • previous version (August 11, 2016 - 05:59).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2017

Author Information

  1. Steven J. Novick,
  2. Wei Zhao and
  3. Harry Yang
  1. MedImmune LLC, Gaithersburg, MD
  1. Corresponding Author: Steven J. Novick, E-mail: novicks{at}medimmune.com.
View Full Text

Cited By...

  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Highly Specific Detection of Oxytocin in Saliva
    Muhit Rana, Nimet Yildirim, Nancy E. Ward, Stephanie P. Vega, Michael J. Heffernan, Avni A. Argun
    International Journal of Molecular Sciences 2023 24 5
  • A novel biosensor for ultrasensitive detection of fungal genes
    Muhit Rana, Tugba Yilmaz, Shirli Cohen, Sinem Beyhan, Avni A. Argun
    Biosensors and Bioelectronics 2023 222
  • Reliability and diagnostic accuracy of corrected slack angle derived from 2D-SWE in quantitating muscle spasticity of stroke patients
    Junyan Cao, Yang Xiao, Weihong Qiu, Yanling Zhang, Zulin Dou, Jie Ren, Rongqin Zheng, Hairong Zheng, Zhaocong Chen
    Journal of NeuroEngineering and Rehabilitation 2022 19 1
  • Biocontamination Control for Pharmaceuticals and Healthcare
    Tim Sandle
    2019
  • The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA‐BIOP Nonclinical Bayesian Working Group
    Paul Faya, Perceval Sondag, Steven Novick, Dwaine Banton, John W. Seaman, Jr, James D. Stamey, Bruno Boulanger
    Pharmaceutical Statistics 2021 20 2
  • Biocontamination Control for Pharmaceuticals and Healthcare
    Tim Sandle
    2024
  • Frequentist and Bayesian tolerance intervals for setting specification limits for left‐censored gamma distributed drug quality attributes
    Richard O. Montes
    Pharmaceutical Statistics 2024 23 2
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 71 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 71, Issue 1
January/February 2017
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data
Steven J. Novick, Wei Zhao, Harry Yang
PDA Journal of Pharmaceutical Science and Technology Jan 2017, 71 (1) 20-32; DOI: 10.5731/pdajpst.2016.006684

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data
Steven J. Novick, Wei Zhao, Harry Yang
PDA Journal of Pharmaceutical Science and Technology Jan 2017, 71 (1) 20-32; DOI: 10.5731/pdajpst.2016.006684
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Two-variance Component (2VC) Gaussian Model
    • 3. Single-variance Component (1VC) Gaussian Model
    • 4. Example Data Set
    • 5. Simulation
    • 6. Discussion
    • Conflict of Interest Declaration
    • Acknowledgments
    • Appendix A1. STAN Computer Code for 2VC Gaussian Model
    • Appendix A2. STAN Computer Code for 1VC Gaussian Model
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Worldwide Regulatory Reliance: Results of an Executed Chemistry, Manufacturing, and Control Post-Approval Change Pilot
  • Preservative Efficacy Testing of Refrigerated Pharmaceuticals: Choice of Challenging Isolate and Storage Temperature
  • Analysis of Virus Clearance for Biotechnology Manufacturing Processes from Early to Late Phase Development
Show more Research

Similar Articles

Keywords

  • Control limits
  • Below limit of quantitation
  • Bayesian
  • Tobit likelihood

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire